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viruses were detected in benign renal neoplasia (0/23), ma-
lignant renal tumours (0/89) or bladder cancer (0/76).  Con-
clusion: Our study did not find any evidence that BKPyV,
KIPyV, WUPyV or HPyV9 are associated with bladder and re-
nal tumours.  © 2016 S. Karger AG, Basel 
 Introduction 
 As all known human pathogenic viruses of the  Poly-
omaviridae family encode early regulatory tumour anti-
gens, the potential oncogenic role of these viruses has 
been suggested  [1–4] since the discovery of the first hu-
man polyomavirus (HPyV), BK polyomavirus (BKPyV) 
 [5] . This suggestion was strengthened by in vitro and an-
imal experiments with BKPyV that proved its transform-
ing ability as reviewed previously  [1, 3, 6] . After the pri-
mary infection, BKPyV establishes a lifelong persistent 
infection in the urinary tract and renal cells  [2] , hence 
there exist large number of studies of urinary tract neo-
plasia and cancers  [7–15] . DNA, RNA or even proteins of 
the BK virus have been detected in different human tu-
mours (brain, neuroblastoma, osteosarcoma, bladder, 
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 Abstract 
 Background/Aims: The oncogenic potential of human poly-
omaviruses (HPyVs) has been proposed, but so far only 
Merkel cell carcinoma polyomavirus seems to be associated 
with a human tumour. The role of BK polyomavirus (BKPyV) 
in human tumourigenesis remains controversial. BKPyV es-
tablishes persistent infection in the urinary tract, and renal 
and bladder neoplasms have been studied extensively, but 
conflicting prevalence data are reported. KI, WU and HPyV9 
were detected in urine samples suggesting that these virus-
es may also infect the urinary tract, but their presence in uri-
nary tract tumours has not been studied. The aim of this work 
was to examine the prevalence of KIPyV, WUPyV, HPyV9 and 
BKPyV by PCR in renal and bladder neoplasms.  Methods: A 
total of 190 formalin-fixed paraffin-embedded renal neo-
plasms, bladder cancer and kidney biopsy samples were an-
alysed for the presence of BKPyV, KIPyV, WUPyV and HPyV9 
DNA by real-time and nested PCR.  Results: Amplifiable DNA 
was extracted from all the samples, but none of the studied 
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kidney, adrenal, prostate, genital, colon), but the role of 
BKPyV in human cancers is still controversial  [1, 4, 6, 
16–19] .
 Although 11 new human pathogenic polyomaviruses 
(KI, WU, Merkel cell polyomavirus, HPyV6, HPyV7, 
trichodysplasia spinulosa-associated polyomavirus, 
HPyV9, HPyV10, STLPyV, HPyV12 and New Jersey 
polyomavirus)  have been discovered since 2007  [20–32] , 
so far only Merkel cell polyomavirus has been associated 
with a rare, cutaneous tumour. This was named Merkel 
cell carcinoma as an aetiological agent  [33] .
 KI and WU polyomaviruses (KIPyV, WUPyV) were 
first described in 2007 from respiratory samples  [20, 21] . 
Subsequent seroepidemiological studies revealed that 
both viruses are widespread, the primary infections of 
which may occur during the early years of life, and adult-
hood seropositivities are 55–100%  [34–36] . Most of the 
important questions about the pathogenesis of KIPyV 
and WUPyV have not been clarified. Their respiratory 
transmission is suggested based on prevalence data from 
numerous studies, as has been summarized in review ar-
ticles  [19, 37, 38] . Both KI and WU viruses were detected 
in urine samples, which suggests that these viruses may 
also infect the urinary tract  [39–41] .
 HPyV9 was first detected in plasma and urine samples 
from renal transplant patients  [25] , following which two 
teams also found the viral DNA in urine samples  [42, 43] . 
The pathogenesis of the transmission of HPyV9 is not 
known, but it seems to be a frequent infectious agent since 
seropositivity in adults reaches 47% and increases with 
age  [44] .
 Some publications about the prevalence of KIPyV, 
WUPyV and HPyV9 in different tumours are available, 
but these viruses have not been hitherto examined in 
bladder and renal cancers  [45–57] . In the present study 
the prevalence of KIPyV, WUPyV, HPyV9 and BKPyV 
were examined by PCR in tissue samples from the urinary 
tract. In order to reveal a possible association of these vi-
ruses with urinary tract tumours, samples from renal and 
bladder neoplasia were examined.
 Materials and Methods 
 Patients and Samples 
 The Regional and Institutional Ethics Committee of the Uni-
versity of Debrecen approved the study (IX-R-052/00016-29/2012). 
One hundred and ninety formalin-fixed paraffin-embedded tissue 
samples were analysed. The samples were submitted for routine 
diagnosis to the Department of Pathology, University of Debrecen, 
between 2010 and 2014. Data relating to the number of kidney bi-
opsies (from renal transplant patients), and benign and malignant 
renal and urinary bladder tumour samples of 180 patients are sum-
marized in  table 1 . Ten-micrometre-thick tissue sections were de-
paraffinised with xylene, then nucleic acid was isolated using the 
High Pure FFPET  DNA Isolation Kit (Roche, Basel, Switzerland) 
according to the manufacturer’s instructions. The quality and 
quantity of DNA eluted in 50 μl was checked with a NanoDrop 
2000c Spectrophotometer (Thermo Scientific, Waltham, Mass., 
USA) and stored at –20  °  C until use.
 Detection of WUPyV, KIPyV, HPyV9 and BKPyV DNA 
 To confirm the effectiveness of nucleic acid extraction, the 
presence of amplifiable DNA, β-globin PCR was used with the 
primers PCO3 (5 ′ ACACAACTGTGTTCACTAGC3 ′ ) and PCO4 
(5 ′ CAACTTCATCCACGTTCACC3 ′ ). Five microliters of DNA 
 Table 1.  Patient and tissue sample data
Tissue samples Patients/samples,
n
Female,
n
Male,
n
Min.–max. age of patients 
(median), years
Renal neoplasia
Renal adenoma 5/5 3 2 6 – 80.7 (64.3)
Renal angiomyolipoma 10/10 9 1 36.3 – 64.3 (58.7)
Renal oncocytoma 8/8 3 5 40.5 – 74.3 (62.2)
Leiomyosarcoma renis 1/1 1 – 57.1
Carcinoma renocellulare renis
Papillary type 11/11 4 7 33.7 – 69.4 (58.7)
Chromophobe type 5/5 3 2 33.3 – 83.6 (59.5)
Clear cell type 69/71 21 48 31 – 81.2 (61.7)
Bladder carcinoma
Uroepithelial carcinoma 68/76 23 45 45.3 – 87.6 (68.6)
Renal biopsy from renal transplant patients 3/3 0 3 31.9 – 52.8 (37.6)
Total 180/190 66 114 6 – 87.6 (63.5)
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were amplified in a final volume of 25 μl containing AmpliTaq 
Gold 360 Master Mix (Applied Biosystems, Foster City, Calif., 
USA) and 10 pmol of primers. The annealing temperature was 
55  °  C. The sequences of the primers and probes along with the data 
and sensitivities of the PCRs are detailed in  table 2 .
 To detect WU and KI virus DNA, nested and duplex real-time 
PCRs were carried out with the primers  [58, 59] and protocols de-
tailed previously  [39, 40] . Plasmids containing the KIPyV and 
WUPyV genomes were used as positive controls kindly provided 
by Tobias Allander from Karolinska Institute (Stockholm, Swe-
den) and David Wang from Washington University (St. Louis, 
Miss., USA)  [21, 60] . HPyV9 was detected with a nested PCR as 
detailed previously  [42] using primers described by Scuda et al. 
 [25] . Plasmid containing HPyV9 genome kindly provided by
Bernhard Ehlers from the Robert Koch Institute (Berlin, Germa-
ny) was used as a positive control. Nested PCRs were carried out 
with 5 μl of template DNA in a GeneAmp 9700 PCR system using 
AmpliTaq Gold 360 Master Mix (Applied Biosystems). The PCR 
products were visualized by electrophoresis in 1.5% agarose gel 
containing ethidium bromide. Real-time PCR with 10 μl of tem-
plate DNA, TaqMan Universal PCR Master Mix and TaqMan 
probes was performed in an Applied Biosystems 7500 real-time 
PCR instrument and analysed by 7500 Software v2.0.6 (Applied 
Biosystems).
 BK virus DNA was checked by real-time PCR according to the 
protocol detailed previously  [61] . A nested PCR was also carried 
out with previously published primers  [62] . Plasmid containing 
the complete genome of BKPyV Dunlop strain (kindly provided 
by Serena Delbue from the University of Milan, Italy) was used as 
a positive control. The first round of BKPyV nested PCR was per-
formed in a final volume of 20 μl containing 5 μl of template DNA, 
0.4 U of Phusion Green hot start high-fidelity polymerase (Ther-
mo Scientific), 4 nmol dNTPs and 10 –10 pmol of each primer 
(PM1+ sense and PM1– antisense). For the second round, 2.5 μl of 
PCR product from the first round was amplified in a 25-μl final 
volume using 0.5 U Phusion Green hot start high-fidelity poly-
merase, 5 nmol of dNTPs and 10 –10 pmol of each primer (BKV+ 
sense and PM2– antisense). The cycling conditions were: 98  °  C for 
30 s, 30 cycles; 98   °   C for 10 s, 60   °   C for 30 s (1st round)/55   °   C for 
30 s (2nd round), 72   °   C for 30 s and a final extension at 72   °   C for
5 min.
 Results and Discussion 
 One hundred and eleven tissue samples from different 
renal neoplasms (adenomas, angiomyolipomas, oncocy-
tomas, leiomyosarcoma and renal renocellular carcino-
mas), 3 kidney biopsy samples and 76 bladder carcinoma 
tissue samples were studied for the presence of HPyV9, 
 Table 2.  Primers and PCR data used to study polyomaviruses
PCR Primer Sequence 5′ → 3′ Target 
gene
Amplicon 
size, bp
Sensitivity 
of PCR 
GEq/PCR
Refer-
ence 
No.
WU and KI
virus nested
PCR
WUKI_OS ATCTRTAGCTGGAGGAGCAGAG VP2 336
1 58WUKI_OAS CCYTGGGGATTGTATCCTGMGGWUKI_IS RTCAATTGCTGGWTCTGGAGCTGC VP2 277WUKI_IAS TCCACTTGSACTTCCTGTTGGG
WU and KI 
virus real-time 
PCR, duplex
KIPyV VP2-3F CTATCCCTGAATACCAGTTGGAAAC
74 5
59
KIPyV VP2-3R GTATGACGCGACAAGGTTGAAG VP2-3
KIPyV VP2-3 probe FAM-TTCCGGGCATCCCAGACTGGC
WUPyV VP1F AACCAGGAAGGTCACCAAGAAG
VP1 76 5WUPyV VP1R TCTACCCCTCCTTTTCTGACTTGT
WUPyV VP1 probe NED-CAACCCACAAGAGTGCAAAGCCTTCC
HPyV9 nested 
PCR
D1-s GGGACAAGCTGTTTTTGTCTGCT VP1 187
1 25D-1as CCCTGAATTTGAGGCATAAGACCAD-2s TGTCTGCTGTTGATATTGTTGGAA VP1 160D-2as GGCATAAGACCAGAGAACAAGC
BKV real-time 
PCR
BKV forward AGCAGGCAAGGGTTCTATTACTAAAT
BKV reverse GAAGCAACAGCAGATTCTCAACA LT 133 4 61
BKV probe FAM-ACCCTAAAGACTTTCCCTCTGATCTACACCAGTTT
BKV nested 
PCR
PM1+ sense TCYTCTGGNNTAAARTCATGCTCC
2 62PM1– antisense AAWTAGRTKCCAACCTATGGAAC LT 548PM2– antisense GGTAGAATACCCYAARGACTTTCC
BKV+ sense GAATGCTTTCTTCTATAGTATGGTATG LT 353
 For each real-time assay TaqMan MGB probe was used. VP1 = Viral protein 1 (major capsid protein) coding region; VP2 = viral protein 2 (capsid pro-
tein) coding region; VP2-3 = viral protein 2 and 3 (capsid protein) coding region; LT = large T antigen coding region; bp = base pair; GEq/PCR = genome 
equivalent/PCR.
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WU, KI and BK. The novel HPyVs were not detected in 
any of the samples and BKPyV positivity was found in 
one kidney biopsy sample from a renal transplant patient. 
However, PCR-amplifiable DNA was extracted from 
each tissue sample.
 Although the prevalence of KIPyV and WUPyV in 
different tumours was investigated and published previ-
ously by some research teams, with the exception of one 
study, no association of these viruses and tumours was 
revealed. In total, 37 and 38 formalin-fixed paraffin-em-
bedded, mucosal melanoma samples  [45, 55] , 25 fresh-
frozen, central nervous system tumours, 31 fresh-fro-
zen, neuroblastoma samples  [46] , 50 neonatal, dried 
blood spots from children who developed later acute 
lymphoblastic leukaemia  [50] , 43 formalin-fixed paraf-
fin-embedded neuroendocrine tumour samples  [48] , 30 
fresh lung adenocarcinomas  [49] and 32 neuroendo-
crine lung tumours  [47] were found to be negative for 
KIPyV and WUPyV DNA by standard  [45–47] and 
nested  [50] real-time PCR  [49] and polyomavirus geno-
typing assay  [48] . Babakir-Mina et al.  [63] detected the 
VP1 region of KIPyV in 9 out of 40 fresh lung cancer 
tissue samples, although only 2 malignant tissue samples 
were positive for the early region of KI virus. These re-
sults revealed that the lung can be the site of infection, 
even if the infected cell type was not identified. In an-
other study, CD68+ cells in lung were found to be posi-
tive for the KIPyV antigen, suggesting that alveolar mac-
rophages might be the site of KIPyV infection  [64] . 
Based on these data it cannot be concluded that KIPyV 
has any role in oncogenesis.
 HPyV9 was examined but not detected in different 
non-Merkel cell carcinoma skin cancers (paraffin-em-
bedded: 41 basal cell carcinoma, 31 actinic keratosis, 8 in 
situ squamous cell carcinoma, 52 squamous cell carcino-
ma, 42 keratoacanthoma, 5 microcystic adnexal carcino-
ma and 14 atypical fibroxanthoma)  [51] , 37 mucosal mel-
anoma samples  [55] , 39 skin and blood samples from pa-
tients with cutaneous T-cell lymphoma  [54] , 31 
formalin-fixed paraffin-embedded samples and 8 frozen 
samples from patients with glioblastoma multiforme 
 [57] , and 27 serum samples from patients with chronic 
lymphocytic leukaemia  [52] by real-time PCR. HPyV9 
DNA was found by deep sequencing in a skin sample 
from a patient with Merkel cell carcinoma  [53] . Low-
quantity HPyV9 DNA was detected in 1 out of the 18 
paraffin-embedded melanoma samples examined  [56] .
 The potential role of BKPyV in the development of 
bladder, renal and other carcinomas has been reviewed 
extensively  [1–3, 19] . The virus is ubiquitous with pri-
mary infections occurring during childhood, and the se-
ropositivity among adults exceeds 90%. The means of 
transmission are suggested to be respiratory, faecal-oral, 
urinary route, transplacental and even through blood 
transfusion and organ transplantation  [2] . After the pri-
mary infection, lifelong persistence is established, main-
ly in the urinary tract  [65, 66] . Active, lytic viral replica-
tion occurs in 5–10% of healthy individuals, resulting in 
virus shedding via urine, but is more frequent in the im-
munocompromised (such as renal transplant patients) 
and is in accordance with the rate of the immunosup-
pression  [67, 68] . BKPyV is able to induce malignant 
transformation in animals and in in vitro cell cultures, 
but studies with human cancers are controversial. The 
presence or absence of BKPyV DNA and/or proteins has 
been reported, hence the role of this virus in human tu-
mourigenesis is not clarified, as reviewed previously  [1, 
3, 19] .
 In our study, BKPyV DNA was not detected in be-
nign and malignant renal neoplasia (0/111) and also
not in bladder cancer (0/76). Nucleic acid extraction 
was successful, resulting in a good quantity of amplifi-
able DNA, and previously used PCR detection methods 
with good sensitivity levels were used ( table 2 ). In addi-
tion, 1 out of the 3 examined renal biopsy samples was 
BKPyV DNA positive. Antigen expression was not ex-
amined.
 Based on our data and previous studies, there is to date 
no evidence that WUPyV, KIPyV or HPyV9 have any role 
in oncogenesis; however, this cannot be definitively ex-
cluded. Although all three viruses have previously been 
detected in urine samples, there is no evidence that these 
viruses infect the urinary tract. Despite the growing vol-
ume of prevalence data, little or hardly anything is known 
about the pathogenesis of KIPyV, WUPyV and HPyV9. 
The cited studies and our new results provide essential 
data regarding the prevalence of novel HPyVs, but more 
samples and studies are needed. Identifying the suscep-
tible cells, sites of infection and possible latencies, as well 
as the isolation of the virions and further in vitro studies 
are necessary for further progression.
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